Direct Healthcare Professional Communication on Opzelura 15 mg/g cream: Important information regarding presence of particles in Opzelura cream
2025.04.24
Active substance: Ruxolitinib phosphate
The company Incyte Biosciences Distribution B.V. informs about possible particles in Opzelura 15 mg/g cream, which may form during production from the active substance. Patients should discontinue use if they notice particles and contact the dispensing pharmacy to receive a replacement free of charge.
Download DHPC/Information letter , Download_VeroeffentlichtAm_EN